Incyte Corp at Guggenheim Healthcare Talks Oncology Day Transcript

Feb 08, 2023 / 06:35PM GMT
Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

All right. Great. It's Michael Schmidt again with the Biotech team from Guggenheim, the next presenting company is Incyte. I'm very excited to welcome Christiana Stamoulis as well as Steven Stein. Welcome, guys, and thanks for joining us.

Steven H. Stein - Incyte Corporation - Executive VP & Chief Medical Officer

Thank you.

Christiana Stamoulis - Incyte Corporation - Executive VP & CFO

Thank you for having us.

Questions and Answers:

Michael Werner Schmidt - Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

So maybe jumping right into questions sort of in continuation of yesterday's earnings call, Christiana. Starting with Jakafi, which obviously has continued to deliver strong growth last year and guidance look very strong as well. I guess maybe talk a bit about in the commercial setting now, what is the main driver of growth of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot